U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H22N2O2.ClH
Molecular Weight 310.819
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISAMOLTAN HYDROCHLORIDE

SMILES

Cl.CC(C)NCC(O)COC1=C(C=CC=C1)N2C=CC=C2

InChI

InChIKey=DCOXRJZVVPMXLY-UHFFFAOYSA-N
InChI=1S/C16H22N2O2.ClH/c1-13(2)17-11-14(19)12-20-16-8-4-3-7-15(16)18-9-5-6-10-18;/h3-10,13-14,17,19H,11-12H2,1-2H3;1H

HIDE SMILES / InChI

Description

Isamoltan (CGP 361A) is a β-adrenoceptor and serotonin 1B receptor antagonist. Isamoltane has reported activity as an anxiolytic in man. Isamoltan had been in phase III clinical trials for the treatment of anxiety. However, this research has been discontinued.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
40.0 nM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
Rats: 3 mg/kg, i.p.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Racemic isamoltane showed a selective interaction with the 5-HT1B receptor, having an IC50 value of approximately 40 nmol/l irrespective of whether [125I]ICYP or [3H]5-HT was used as ligand.